Background and objective: Smokers develop respiratory symptoms and peripheral airway dysfunction even when spirometry is preserved. Multiple breath nitrogen washout (MBNW) and impulse oscillometry system (IOS) are potentially useful measures of peripheral airway function but they have not been compared in such subjects. We hypothesized that MBNW and IOS are jointly abnormal in smokers with normal spirometry and that these abnormalities relate to respiratory symptoms. Methods: Eighty smokers with normal spirometry completed a symptom questionnaire, had ventilation heterogeneity in diffusion (Sacin) and convectiondependent (Scond) airways and trapped gas volume at functional residual capacity as a percentage of vital capacity (%VtrFRC/VC) measured by MBNW. Respiratory resistance and reactance at 5 and 20 Hz were measured using IOS. Results: Respiratory symptoms were reported in 55 (68%) subjects. Forty (50%) subjects had at least one abnormal MBNW parameter, predominantly in Sacin. Forty-one (51%) subjects had at least one abnormal IOS parameter, predominantly in resistance. Sixty-one (76%) subjects had an abnormality in either MBNW or IOS. Chronic bronchitis symptoms were associated with an increased Scond, while wheeze was associated with lower spirometry and an increased resistance. Abnormalities in MBNW and IOS parameters were unrelated to each other. Conclusions: Respiratory symptoms and peripheral airway dysfunction are common in smokers with normal spirometry. Symptoms of chronic bronchitis related to conductive airway abnormalities, while wheeze was related to spirometry and IOS. The clinical significance of abnormalities in peripheral airway function in smokers remains undetermined.
INTRODUCTION
Abnormal peripheral airway function and symptoms are common in smokers without COPD. The typical symptoms of cough and mucus production lead to increased health care utilization and exacerbations. 1 Although the pathophysiologic basis of symptoms in smokers without COPD is unknown, smokers have structural abnormalities of airways and lung parenchyma. The walls of medium-sized airways are thickened 1 ; there is regional hyperinflation 2 and inflammation and epithelial damage of the membranous airways. 3 Another very 
SUMMARY AT A GLANCE
Multiple breath nitrogen washout (MBNW) or impulse oscillometry system (IOS) abnormalities were highly prevalent in smokers without COPD but highly discordant between individuals. Cough was related to peripheral conductive airway function, while wheeze was related to IOS and spirometry. In smokers with normal spirometry, MBNW and IOS abnormalities may have different underlying structural bases and prognostic significance.
prominent finding is respiratory bronchiolitis characterized by oedema and fibrosis. 3, 4 In subsequent studies, a progressive loss of small airways due to bronchiolitis eventually leading to COPD has been shown. 5 Small airway abnormalities in smokers with normal spirometry should indicate early smoking-related damage, which in some may progress to COPD. Little is known of the clinical significance of small airway abnormalities measured by current methods in these smokers.
Small airway function can be measured using the single breath nitrogen washout (SBNW) test which is a highly sensitive indicator of ventilation distribution and airway closure. The majority of smokers had abnormalities in SBNW and were strongly associated with cumulative smoking history. 6 However, whether abnormalities in SBNW predicted COPD risk were contradictory. 7, 8 Other published data suggested that early emphysema, hyperinflation or expiratory gas trapping measured by computed tomography (CT) 2, 9 and diffusing capacity of the lung for carbon monoxide (DL CO ), 10 may be useful markers of small airway disease since their abnormalities are associated with forced expiratory volume in 1 s (FEV 1 ) decline in smokers without COPD. Although hyperinflation and gas trapping measured by plethysmography may indicate small airway dysfunction, there are no published physiologicpathologic correlations which confirm this, nor any published associations with FEV 1 decline. As yet, no markers have been shown to be useful predictors of COPD risk in prospective studies. Newer tests of small airway function, the multiple breath nitrogen washout (MBNW) test and respiratory system impedance measured by the impulse oscillometry system (IOS-a variant of the forced oscillation technique (FOT)), again show that cigarette smoking is associated with abnormal function when spirometry is normal. [11] [12] [13] Whether MBNW and FOT identify the same abnormalities in peripheral airways, and whether they relate to symptoms is unknown.
MBNW provides measures of ventilation heterogeneity, separating this into a convection-dependent component likely related to peripheral conducting airways (Scond) and a component dependent on the interaction between convention and diffusion (involving airways beyond the convection-dependent airways) likely related to acinar airways (Sacin).
14 The IOS produces indices of resistance (R) and reactance (X), which reflect airway calibre and oscillatory stiffness of the respiratory system. 15 Therefore, the MBNW and FOT indices may be useful clinically in detecting early airways disease in smokers without COPD, particularly if they relate to respiratory symptoms.
Our aims were to determine the prevalence of functional abnormalities identified by MBNW and IOS in current and ex-smokers with normal spirometry, and to examine the interrelationships between IOS and MBNW indices. We also aimed to examine the relationships between both IOS and MBNW indices, and respiratory symptoms and smoking history. We hypothesized that both respiratory mechanics measured by IOS and ventilation distribution measured by MBNW, identify small airway abnormalities that are related to respiratory symptoms in current and exsmokers with normal spirometry. Some of these data have been previously published in a sub-study examining bronchodilator responses. 12 The latter study's hypothesis and research questions do not overlap with those in the present study.
METHODS

Subjects
Eighty young current or ex-smokers (≤50 years) with a smoking history of >5 pack-years and no history of past/present cardiac and respiratory diseases were recruited from the community. Subjects were included if they had normal spirometry, defined as postbronchodilator FEV 1 Z-score ≥−1.645 and FEV 1 /forced vital capacity (FVC) Z-score ≥−1.645. 16 All current smokers were instructed to abstain from smoking at least 1 h before testing. Written informed consent was obtained from all participants. The study protocol was approved by the Northern Sydney Central Coast Area Health Service Human Research Ethics Committee (Protocol 1106-209M).
Study design
This was a prospective, observational study in which subjects were tested in a single session at the Woolcock Institute of Medical Research and the Royal North Shore Hospital, Sydney, Australia. A history of respiratory symptoms in the previous year was obtained through the standard Woolcock respiratory questionnaire. Symptoms were characterized by the following three domains. Chronic bronchitis defined by a positive answer to any of the following: 'Do you usually have cough?', 'Do you cough for as much as 3 months of the year?' or 'Do you usually bring up phlegm from your chest first thing in the morning?'. Secondly, dyspnoea was defined as a positive answer to any of the following: 'In the last 12 months, have you had an attack of shortness of breath that came on when you were not exercising and without obvious cause?' or 'Have you been troubled by shortness of breath when hurrying on level ground or walking up a hill?'. Finally, wheeze was defined as a positive answer to: 'Have you wheezed in the last 12 months?' Subjects performed spirometry, body plethysmography, DL CO , IOS and MBNW. Finally, all subjects performed post-bronchodilator spirometry 20 min after inhalation of 200 μg of salbutamol and 80 μg of ipratropium bromide via metered dose inhaler and large volume spacer.
Spirometry, plethysmography and DL CO
Spirometry, whole-body plethysmography and DL CO were performed according to the American Thoracic Society (ATS)/European Respiratory Society (ERS) Guidelines, using a Medisoft BodyBox 5500 (Medisoft Corporation, Sorrines, Belgium). 17, 18 Values are reported as percentage of predicted values. 16, 19, 20 According to ATS/ERS recommendations for DL CO , normal is defined as DL CO ≥75% pred . 21 Both residual volume (RV)/total lung capacity (TLC) ratio and the ratio of alveolar volume (VA) from the DL CO measurement to TLC ratio (VA/TLC) were used as measures of gas maldistribution. 22 
Impulse oscillometry system
Respiratory system impedance was then measured using a Jaeger Masterscope CT IOS (CareFusion, Hoechberg, Germany). Short pulses of pressure waves were generated by a loudspeaker and superimposed onto tidal breathing for 20 s, which yielded impedance values at multiples of 5 Hz from 5 to 35 Hz. Technically acceptable triplicate recordings were obtained to derive: respiratory resistance at 5 Hz (R5), 20 Hz (R20), the difference between R5 and R20 (R5−R20) and reactance at 5 Hz (X5). Subjects sat upright, had a nose clip and mouthpiece and firmly supported their cheeks with their hands.
Multiple breath nitrogen washout
Triplicate measurements on an in-house built MBNW device were obtained to derive indices of ventilation heterogeneity. 12 Subjects breathed 100% oxygen with tidal volume of 1.0-1.3 L at a breath rate of 9-12/min, until end-tidal nitrogen concentration reached 1/40th of the starting alveolar nitrogen concentration. Subjects then inhaled five slow deep breaths from FRC to total lung capacity, followed by a slow exhalation to RV to derive the trapped gas volume at functional residual capacity as a percentage of vital capacity (%VtrFRC/ VC). 23 Scond and Sacin were derived from the three tests as previously described.
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Statistical analysis
Data were analysed using SPSS software (IBM, SPSS, V21, NY, USA). Spearman correlation coefficients were calculated to assess the relationships between lung function parameters. Spirometry and plethysmographic lung volumes are presented as means (SD). All other functional data are presented as median (interquartile range, IQR). Sacin and Scond were expressed as both raw values and Z-scores based on published predicted values.
12 R5 and X5 were also expressed as both raw values and Z-scores based on published predicted values. 24 A Z-score >+1.96 was considered abnormal for both MBNW and IOS parameters, except X5 where < −1.96 was abnormal. Differences in spirometry and plethysmographic volumes between subjects grouped by the three symptom domains (cough and sputum, dyspnoea and wheeze) were examined using unpaired ttests. Differences in MBNW and IOS parameters between subjects grouped by the three symptom domains were examined using Mann-Whitney U-tests, on Z-scores. Concordance between MBNW and IOS was assessed using Cohen's kappa statistic. P-values <0.05 were considered significant.
RESULTS
Anthropometric characteristics, spirometry, plethysmographic lung volumes and diffusion are shown in Table 1 . Sixteen subjects (20%) were ex-smokers, of these 8 had only quit smoking for less than a year, 5 had quit smoking for 2-5 years and 3 had quit smoking for 5-20 years. The mean plethysmographic lung volumes of the group were normal. Mean DL CO for the entire cohort was normal although there was a wide range of values. Only 5 of 80 subjects had significant bronchodilator (BD) responses on spirometry by ATS criteria.
Prevalence of MBNW and IOS abnormalities
MBNW and IOS results are shown in Table 2 . Forty subjects (50%) had an abnormal Sacin and/or Scond. Of these, 23 (29%) had an abnormal Sacin only, while 6 (7%) had an abnormal Scond only and 11 subjects (14%) had both. Similarly, 41 subjects (51%) had an abnormality in R5 and/or X5. Of these, all had an abnormal R5 while 6 (7%) had an abnormal X5. In exsmokers, the prevalence of abnormalities in Sacin and/or Scond (48%), and in R5 and/or X5 (47%) were similar to the group as a whole. Table 3 shows the occurrence of IOS and MBNW abnormalities. Sixty (75%) had an abnormality in at least one MBNW or IOS parameter, with 21 (25%) having an abnormality in both MBNW and IOS. There was only a small degree of overlap in the abnormalities in MBNW (either Scond or Sacin) and in IOS (either R5 or X5) (Cohen's κ < 0.2). Approximately, a quarter had an abnormal MBNW parameter alone (19 subjects) and a quarter had an abnormal IOS parameter alone (20 subjects). A similar degree of discordance in abnormalities was seen in ex-smokers (Cohen's κ < 0.1).
Comparison between symptomatic and asymptomatic subjects
Thirty-one subjects (39%) reported respiratory symptoms of chronic bronchitis; 39 (49%) reported episodic wheeze and 30 (38%) reported shortness of breath at rest and/or on exertion. Overall 55 of 80 (68%) subjects reported at least one symptom.
Differences in spirometry, IOS and MBNW between symptomatic and asymptomatic subjects according to the three specified symptom domains were examined. The significant differences are reported as follows. Subjects who reported symptoms of chronic bronchitis had a higher Scond (Z-score 0.54 (−0.22-2.58) vs 0.24 (−0.54-1.16); P = 0.043) compared to those without chronic bronchitis symptoms. Those who reported shortness of breath had a borderline lower postbronchodilator FEV 1 % predicted (99.1 (11.1) vs 104.3 (11.6); P = 0.06) compared to those who did not. Those who reported wheeze, had a higher R5 (Z-score 1.89 (1.16-2.51) vs 1.37 (0.77-1.88); P = 0.02), R20 (Z-score 1.52 (0.91-2.3) vs 0.97 (0.50-1.82); P = 0.03) and lower FEV 1 % predicted (96.4 (11.7) vs 106.6 (11.5); P = 0.01), and FEF 25- There were no differences in smoking history, age, gas trapping between those who reported symptoms versus those who did not within these three symptom domains.
MBNW and IOS relationships with smoking, spirometry and gas trapping
Correlations of MBNW and IOS indices, with spirometry and gas trapping are shown in Table 4 . Scond and Sacin were both unrelated to spirometry parameters, to RV/TLC or to VA/TLC. Only Sacin Z-score correlated with %VtrFRC/VC (r s = 0.23, P = 0.049). R5 Z-score correlated with FEV 1 % predicted and FEF 25-75 % predicted. Both R5 and X5 Z-scores were unrelated to RV/TLC%, VA/TLC (Table 4) or to smoking history (r s = −0.07, P = 0.62; r s = 0.06, P = 0.55, respectively).
The correlations between MBNW and IOS indices are shown in Figure 1 . Scond Z-score correlated with R5 (r s = 0.23, P = 0.04), X5 Z-scores (r s = 0.29, P = 0.008) (Fig. 1) and to standardized residuals of R5-R20 (r s = 0.22, P = 0.049) but not to R20 Z-score. Sacin Z-score was unrelated to all IOS indices. Scond was unrelated to smoking history (0.17, P = 0.14). The only MBNW or IOS parameter that correlated with smoking history was Sacin, and only in subjects whose Sacin was abnormal (r s = 0.37, P = 0.03, Fig. 2 ).
DISCUSSION
We found that abnormalities in either MBNW or IOS were common and were present in three-fourth of young to middle-aged smokers with normal spirometry. Approximately, a quarter of our cohort had an abnormal MBNW parameter alone, a quarter had an abnormal IOS parameter alone and a quarter had an abnormality in both IOS and MBNW. Symptoms of chronic bronchitis were related to Scond, while wheeze and dyspnoea related to R5 and to spirometry. IOS and MBNW were unrelated to gas trapping (RV/TLC) or diffusion.
The high prevalence of MBNW and IOS abnormalities was a surprise but suggests that in smokers, there are subtle abnormalities commonly present and that spirometry is insensitive to them. The fact that spirometry requires a forced manoeuvre, whereas MBNW and IOS being tidal measurements, may influence the likelihood of detecting abnormal airway function in smokers. The high prevalence of abnormality in either IOS or MBNW in the presence of normal spirometry supports the notion that there are peripheral airway abnormalities present. SBNW phase III slopes and closing volumes have been correlated with histological emphysema and small airway abnormalities in smokers, 25 however, such correlative studies have not been done for either IOS or MBNW.
The proportion of smokers identified with abnormalities in MBNW (predominantly Sacin) and in IOS (predominantly R5) were similar but occurred in different subjects, that is, about a half of the subjects with abnormal MBNW had normal IOS and about a half of the subjects with abnormal IOS had normal MBNW. This is consistent with the fact that Scond correlated only with R5 (which was weak, see Fig. 1 ) and with R5-R20, whereas other relationships between MBNW and IOS parameters were not significant. In another small study of healthy, asthmatic and cystic fibrosis patients, there were little to no correlations between impedance and MBNW. 26 The discordance between abnormalities in IOS and MBNW are difficult to explain. Both tests are sensitive to heterogeneities in ventilatory unit function, but the fundamental differences in the techniques may explain the lack of concordance. Oscillatory impedance is sensitive to widespread and peripheral airway narrowing with more severe narrowing in proximal airways. 27, 28 This might presumably occur in some without altering ventilation distribution in the lung periphery due to a uniform distribution of abnormality. However, such an explanation is unlikely given the very large number of airways in the lung periphery. Conversely, ventilation may become heterogeneous in the lung periphery without altering impedance, either due to lack of proximal airway involvement or due to involvement of some airways while others remain unaffected.
Resistance was abnormal in 41 subjects whereas only 6 subjects had an abnormal reactance. One possible explanation for the discordance between parameters is that they are sensitive to different mechanical changes in the airway tree. Resistance is affected by multiple factors, including narrowing with a reduction in overall mean calibre, particularly when the narrowing is heterogeneous, widespread and involving the central airways. 24 Reactance is also sensitive to heterogeneous and widespread airway narrowing but with the addition of closure. 28, 29 Indeed, airway closure (during tidal breathing) in this cohort was mild with trapped gas volume of around 4% of vital capacity compared to the 10% of vital capacity reported in asthmatics. 30 Abnormities in reactance are usually accompanied by abnormalities in resistance and in frequency dependence of resistance (R5-R20; r s = −0.68, P = 0.001), which we also observed in the present study. It is unknown whether resistance or reactance are more sensitive to small airways dysfunction but results of the present study suggest that with IOS, they are not equivalent.
Symptoms associated with smoking may be related to smoking-induced alterations in the airway wall. Symptomatic smokers were found to have thicker airway walls visualized by HRCT, albeit in an older cohort. 1 The authors suggested that these data of thickened proximal airways may represent associated small airways remodelling based on published correlations between HRCT and histology in smokers. 31 Proximal wall thickening due to inflammation might explain the association observed in the present study between Scond and symptoms of bronchitis. However, symptoms are highly subjective and along with the high prevalence of functional abnormalities, one would expect no or weak relationships with lung function. The differences in R5, Scond and spirometry between symptomatic and asymptomatic smokers in the present study were small, with the medians and means of the symptomatic groups being within the normal range, albeit with a wide range. Indeed, in a study of smokers with normal spirometry, there was no association found between symptoms and airway wall thickening on CT. 32 In the same study, gas trapping and emphysema were associated with smoking but not with symptoms. Therefore, the structural basis behind respiratory symptoms in smokers with normal spirometry remains uncertain.
Forty percent of the smokers exhibited abnormal DL CO , however, this was not related to MBNW/IOS or to smoking history. The DL CO may not necessarily reflect early emphysema, since it may be due to other smoking-related changes, including altered membrane diffusion, pulmonary vascular changes and increased carboxyhaemoglobin which were not measured in this cohort. 33, 34 In smokers with normal spirometry but emphysema on CT, DL CO was reduced in only about half of smokers. 35 Although respiratory impedance measured by FOT in COPD related to CT-measured emphysema, 36 this may not necessarily apply to non-COPD smokers. Ventilation imaging with hyperpolarized He 3 MRI is also sensitive to early emphysema, 37 with airway thickening and early emphysema observed in about two-thirds of smokers with normal spirometry. 31 Therefore, the high prevalence of peripheral airway abnormalities observed in the present study are consistent with findings of imaging studies.
Peripheral airway function in smokers is potentially useful as a measure of early smoking-related disease, over and above symptoms and CT, if indeed the loss of terminal airways precedes spirometric and emphysematous changes. 5 Sputum production, 38 gas trapping, 2, 9 airway hyper-responsiveness 39 and continued smoking 40 are known to predict FEV 1 decline. Although SBNW measures show little utility in predicting decline in FEV 1 , 7,8 our finding highlight the need to better understand the relationship between impedance measures and MBNW, and accelerated FEV 1 decline in smokers.
We studied smokers <50 years of age who had smoked between 8 and 40 pack-years. Limiting the study to young subjects avoided the potential confounding effects of age on Sacin, which becomes much more variable over the age of 60 years. 41 We limited the study to 40 pack-years or less since we reasoned that young individuals who had smoked >40 pack-years and had normal spirometry, would be unlikely to develop COPD and could also be less likely to have peripheral airway abnormalities. The results of the present study therefore only apply to smokers under 50 years of age with <40 pack-years of smoking exposure. Given the disparity between IOS and MBNW, it would have been useful to have structural and functional imaging data, which would have provided insights into the discordance in abnormal measurements. In asymptomatic smokers identified by case finding with early COPD, there could be differences in IOS and MBNW, which could provide further insights into the basis of symptoms in early COPD.
In conclusion, we report respiratory symptoms and abnormalities in peripheral airway function, measured by MBNW and IOS, to be common in smokers with normal spirometry. Furthermore, abnormal IOS and MBNW indices occurred in different individuals. Symptoms of chronic bronchitis related to peripheral conductive airways function, while wheeze was related to measures of large airway function. Future prospective studies are required to determine whether abnormal MBNW and IOS parameters have any prognostic significance in smokers.
